Back to search

Article

NLR Dynamics During CDK4/6 Inhibition Predict Overall Survival in Metastatic Breast Cancer

2026-07-29

Abstract excerpt

<h4>Background: </h4> /Objectives: In metastatic breast cancer (MBC) treated with CDK4/6 inhibitors, baseline neutrophil-to-lymphocyte ratio (NLR) is an established prognostic marker. On-treatment NLR dynamics have shown inconsistent associations with survival, and no prior study has decomposed change into neutrophil-driven and lymphocyte-driven components. <h4>Methods:</h4> We retrospectively analyzed 352 patient...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8d58d4b6-c98a-57b8-a23b-9ee6d6c63870
DOI
10.20944/preprints202607.2090.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
NLR Dynamics During CDK4/6 Inhibition Predict Overall Survival in Metastatic Breast CancerDOI 10.20944/preprints202607.2090.v1
Genomic Markers of CDK 4/6 Inhibitor Resistance in Hormone Receptor Positive Metastatic Breast CancerSemantic proximity
Dissecting sources of variability in patient response to targeted therapy: anti-HER2 therapies as a case studySemantic proximity
Minimal Residual Disease as a Biological Trait: Rethinking Disease Persistence in Hematologic Malignancies.Semantic proximity
Racial Disparities in Neutrophil Counts Among Patients with Metastatic Breast Cancer during Treatment with CDK4/6 InhibitorsSemantic proximity
Predictors of Response to CDK4/6i Retrial After Prior CDK4/6i Failure in ER+ Metastatic Breast CancerSemantic proximity
Impact of initial treatment and prognostic factors on postprogression survival in BRAF-mutated metastatic melanoma treated with dacarbazine or vemurafenib ± cobimetinib: a pooled analysis of four clinical trials.Semantic proximity
Reconstructing tumor trajectories during therapy through integration of multiple measurement modalitiesSemantic proximity
Single-cell transcriptomics reveals biomarker heterogeneity linked to CDK4/6 Inhibitor resistance in breast cancer cell linesSemantic proximity
Select a neighboring publication to make it the new centre.